KalVista Pharmaceuticals

$24.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.75 (-2.98%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KALV and other stocks, options, and ETFs commission-free!

About KALV

KalVista Pharmaceuticals, Inc. Common Stock, also called KalVista Pharmaceuticals, is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors.

CEO
T. Andrew Crockett
Employees
56
Headquarters
Cambridge, Massachusetts
Founded
2004
Market Cap
616.74M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
366.50K
High Today
$25.20
Low Today
$24.02
Open Price
$25.20
Volume
319.26K
52 Week High
$45.00
52 Week Low
$9.03

KALV Earnings

-$0.61
-$0.41
-$0.20
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Jul 1, Pre-Market

You May Also Like

DDEC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure